BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
BEHAVIORAL TREATMENT OF RAYNAUD'S PHENOMENON
批准号:
2216664
负责人:
ROBERT R FREEDMAN
金额:
$20.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1996-12-31
关键词:
Raynaud's disease alpha adrenergic receptor alpha antiadrenergic agent autogenic training behavioral medicine beta adrenergic receptor body temperature brain circulation cold temperature family genetics fingers gender difference gene mutation human subject human therapy evaluation injection /infusion linkage mapping magnetic resonance imaging norepinephrine plethysmography skin circulation vascular endothelium vasoconstriction vasodilation vasospasm
中文摘要
我们最近证明了雷诺氏病的血管痉挛发作
尽管数字神经被封锁,但仍可引发疾病,而且局部
降温可增加未发现的α-肾上腺素能反应性
在正常志愿者中。为了更准确地确定该病的病因
原发性雷诺氏病,有必要确定是否
α1受体和/或α2受体的异常
血管痉挛发作所必需的。我们建议
通过动脉内注入一种α1拮抗剂来研究这个问题,
一个alpha2拮抗者,两个拮抗者都在用
环境和局部降温(研究1)。自我们的调查以来
到目前为止使用的合成肾上腺素能药物,重要的是要确定
这种内源性血管收缩化合物参与了雷诺氏病的发作。
由于去甲肾上腺素在外周血管中的效力很高
肾上腺素受体,我们建议研究它在冷却和非冷却条件下的作用。
雷诺病患者和对照组的手指(研究2)。
我们已经发现阿尔法肾上腺素能受体的异常。
雷诺病患者,最近表现为家族性
这种混乱的集合。因为阿尔法肾上腺素能受体
基因控制,我们建议看看这些基因的突变是否
与雷诺病的发生有关(研究5)。
我们已经证明,反馈诱导的血管扩张部分是通过
一种非神经性β-肾上腺素能血管扩张机制
血浆儿茶酚胺的变化。Aβ-肾上腺素能血管扩张剂
与反馈诱导血管扩张具有相同时程的机制
最近在血管内皮细胞上被证实。我们建议
确定血管内皮细胞参与反馈诱导
使用一种特定抑制内皮的化合物进行血管扩张-
介导的血管扩张(研究3)。
尽管关于温度生物反馈的研究很多,但很少有人做过。
与之相关的大脑机制。一种新的磁共振成像(MRI)
该方法允许无创测量脑血流量
极佳的空间和时间分辨率。我们建议测量大脑
体温反馈训练前后磁共振血流的变化
可靠的控制程序(研究4)。
英文摘要
We have recently demonstrated that the vasospastic attacks of Raynaud's
disease can be provoked despite digital nerve blockade and that local
cooling produces increases in alpha-adrenergic responsiveness not found
in normal volunteers. To more precisely determine the etiology of
primary Raynaud's disease, it is necessary to determine whether
abnormalities of alpha1 receptors, alpha2 receptors, or both are
necessary for the occurrence of a vasospastic attack. We propose to
examine this question by infusing intraarterially an alpha1 antagonist,
an alpha2 antagonist, and both antagonists while provoking attacks with
environmental and local cooling (Study 1). Since our investigations have
thus far utilized synthetic adrenergic drugs it is important to determine
the endogenous vasoconstrictive compound involved in Raynaud's attacks.
Since norepinephrine is highly potent at peripheral vascular
adrenoceptors, we propose to study its effects in cooled and uncooled
fingers of Raynaud's disease patients and controls (Study 2).
We have identified abnormalities of alpha-adrenergic receptors in
Raynaud's disease patients and have recently demonstrated familial
aggregation of this disorder. Since alpha-adrenergic receptors are under
genetic control, we propose to see if mutations of these genes are
involved in the occurrence of Raynaud's disease (Study 5).
We have shown that feedback-induced vasodilation is mediated in part by
a nonneural beta-adrenergic vasodilating mechanism and not through
changes in plasma catecholamines. A beta-adrenergic vasodilating
mechanism having the same time course as feedback-induced vasodilation
has recently been demonstrated on vascular endothelium. We propose to
determine the involvement of vascular endothelium in feedback-induced
vasodilation using a compound that specifically inhibits endothelium-
mediated vasodilation (Study 3).
Despite much research on temperature biofeedback, little has been done
on the brain mechanisms involved. A new MRI (magnetic resonance imaging)
method permits the noninvasive measurement of brain blood flow with
excellent spatial and temporal resolution. We propose to measure brain
blood flow by MRI before and after training in temperature feedback or
a credible control procedure (Study 4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:8120340
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:8120338
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:8120341
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:8120342
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:8120339
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:8120343
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8120335
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:8120337
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:8120336
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2010
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:8515782
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
REGULATION OF CHRNA7 EXPRESSION
-
批准号:7752182
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
STATISTICAL GENETICS AND TREATMENT ANALYSIS
-
批准号:7752199
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
ADMINISTRATION AND DATABASE
-
批准号:7752198
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN CHRNA7 MODELS IN MICE
-
批准号:7752195
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
HUMAN PERINATAL INTERVENTION
-
批准号:7752181
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MOLECULAR AND NEUROBIOLOGICAL MODELS
-
批准号:7752190
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
NICOTINIC CHOLINERGIC RECEPTOR AGONISTS
-
批准号:7752204
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION
-
批准号:7752197
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
CHOLINERGIC TREATMENT OF SCHIZOPHRENIA
-
批准号:7752180
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2009
-
负责人:ROBERT R FREEDMAN
-
依托单位:
MENOPAUSAL HOT FLASHES
-
批准号:7349398
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2006
-
负责人:ROBERT R FREEDMAN
-
依托单位:
海外基金